Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1997 Jan;71(1):697–704. doi: 10.1128/jvi.71.1.697-704.1997

Formation of native hepatitis C virus glycoprotein complexes.

V Deleersnyder 1, A Pillez 1, C Wychowski 1, K Blight 1, J Xu 1, Y S Hahn 1, C M Rice 1, J Dubuisson 1
PMCID: PMC191102  PMID: 8985401

Abstract

The hepatitis C virus (HCV) glycoproteins (E1 and E2) interact to form a heterodimeric complex, which has been proposed as a functional subunit of the HCV virion envelope. As examined in cell culture transient-expression assays, the formation of properly folded, noncovalently associated E1E2 complexes is a slow and inefficient process. Due to lack of appropriate immunological reagents, it has been difficult to distinguish between glycoprotein molecules that undergo productive folding and assembly from those which follow a nonproductive pathway leading to misfolding and aggregation. Here we report the isolation and characterization of a conformation-sensitive E2-reactive monoclonal antibody (H2). The H2 monoclonal antibody selectively recognizes slowly maturing E1E2 heterodimers which are noncovalently linked, protease resistant, and no longer associated with the endoplasmic reticulum chaperone calnexin. This complex probably represents the native prebudding form of the HCV glycoprotein heterodimer. Besides providing a novel reagent for basic studies on HCV virion assembly and entry, this monoclonal antibody should be useful for optimizing production and isolation of native HCV glycoprotein complexes for serodiagnostic and vaccine applications.

Full Text

The Full Text of this article is available as a PDF (561.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bergeron J. J., Brenner M. B., Thomas D. Y., Williams D. B. Calnexin: a membrane-bound chaperone of the endoplasmic reticulum. Trends Biochem Sci. 1994 Mar;19(3):124–128. doi: 10.1016/0968-0004(94)90205-4. [DOI] [PubMed] [Google Scholar]
  2. Braakman I., Helenius J., Helenius A. Manipulating disulfide bond formation and protein folding in the endoplasmic reticulum. EMBO J. 1992 May;11(5):1717–1722. doi: 10.1002/j.1460-2075.1992.tb05223.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bredenbeek P. J., Frolov I., Rice C. M., Schlesinger S. Sindbis virus expression vectors: packaging of RNA replicons by using defective helper RNAs. J Virol. 1993 Nov;67(11):6439–6446. doi: 10.1128/jvi.67.11.6439-6446.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Doms R. W. Oligomerization and protein transport. Methods Enzymol. 1990;191:841–854. doi: 10.1016/0076-6879(90)91051-7. [DOI] [PubMed] [Google Scholar]
  5. Dubuisson J., Rice C. M. Hepatitis C virus glycoprotein folding: disulfide bond formation and association with calnexin. J Virol. 1996 Feb;70(2):778–786. doi: 10.1128/jvi.70.2.778-786.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Elbers K., Tautz N., Becher P., Stoll D., Rümenapf T., Thiel H. J. Processing in the pestivirus E2-NS2 region: identification of proteins p7 and E2p7. J Virol. 1996 Jun;70(6):4131–4135. doi: 10.1128/jvi.70.6.4131-4135.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fischer G., Schmid F. X. The mechanism of protein folding. Implications of in vitro refolding models for de novo protein folding and translocation in the cell. Biochemistry. 1990 Mar 6;29(9):2205–2212. doi: 10.1021/bi00461a001. [DOI] [PubMed] [Google Scholar]
  8. Fuerst T. R., Niles E. G., Studier F. W., Moss B. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci U S A. 1986 Nov;83(21):8122–8126. doi: 10.1073/pnas.83.21.8122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gething M. J., Sambrook J. Protein folding in the cell. Nature. 1992 Jan 2;355(6355):33–45. doi: 10.1038/355033a0. [DOI] [PubMed] [Google Scholar]
  10. Grakoui A., McCourt D. W., Wychowski C., Feinstone S. M., Rice C. M. A second hepatitis C virus-encoded proteinase. Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10583–10587. doi: 10.1073/pnas.90.22.10583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Grakoui A., Wychowski C., Lin C., Feinstone S. M., Rice C. M. Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol. 1993 Mar;67(3):1385–1395. doi: 10.1128/jvi.67.3.1385-1395.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hammond C., Helenius A. Quality control in the secretory pathway. Curr Opin Cell Biol. 1995 Aug;7(4):523–529. doi: 10.1016/0955-0674(95)80009-3. [DOI] [PubMed] [Google Scholar]
  13. Han J. H., Shyamala V., Richman K. H., Brauer M. J., Irvine B., Urdea M. S., Tekamp-Olson P., Kuo G., Choo Q. L., Houghton M. Characterization of the terminal regions of hepatitis C viral RNA: identification of conserved sequences in the 5' untranslated region and poly(A) tails at the 3' end. Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):1711–1715. doi: 10.1073/pnas.88.5.1711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hijikata M., Kato N., Ootsuyama Y., Nakagawa M., Shimotohno K. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5547–5551. doi: 10.1073/pnas.88.13.5547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hijikata M., Mizushima H., Akagi T., Mori S., Kakiuchi N., Kato N., Tanaka T., Kimura K., Shimotohno K. Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. J Virol. 1993 Aug;67(8):4665–4675. doi: 10.1128/jvi.67.8.4665-4675.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hijikata M., Shimizu Y. K., Kato H., Iwamoto A., Shih J. W., Alter H. J., Purcell R. H., Yoshikura H. Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes. J Virol. 1993 Apr;67(4):1953–1958. doi: 10.1128/jvi.67.4.1953-1958.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hilton D. J., Watowich S. S., Murray P. J., Lodish H. F. Increased cell surface expression and enhanced folding in the endoplasmic reticulum of a mutant erythropoietin receptor. Proc Natl Acad Sci U S A. 1995 Jan 3;92(1):190–194. doi: 10.1073/pnas.92.1.190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hochstenbach F., David V., Watkins S., Brenner M. B. Endoplasmic reticulum resident protein of 90 kilodaltons associates with the T- and B-cell antigen receptors and major histocompatibility complex antigens during their assembly. Proc Natl Acad Sci U S A. 1992 May 15;89(10):4734–4738. doi: 10.1073/pnas.89.10.4734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hruby D. E., Guarino L. A., Kates J. R. Vaccinia virus replication. I. Requirement for the host-cell nucleus. J Virol. 1979 Feb;29(2):705–715. doi: 10.1128/jvi.29.2.705-715.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kolykhalov A. A., Feinstone S. M., Rice C. M. Identification of a highly conserved sequence element at the 3' terminus of hepatitis C virus genome RNA. J Virol. 1996 Jun;70(6):3363–3371. doi: 10.1128/jvi.70.6.3363-3371.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lanford R. E., Notvall L., Chavez D., White R., Frenzel G., Simonsen C., Kim J. Analysis of hepatitis C virus capsid, E1, and E2/NS1 proteins expressed in insect cells. Virology. 1993 Nov;197(1):225–235. doi: 10.1006/viro.1993.1583. [DOI] [PubMed] [Google Scholar]
  22. Lin C., Lindenbach B. D., Prágai B. M., McCourt D. W., Rice C. M. Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini. J Virol. 1994 Aug;68(8):5063–5073. doi: 10.1128/jvi.68.8.5063-5073.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Mizushima H., Hijikata M., Asabe S., Hirota M., Kimura K., Shimotohno K. Two hepatitis C virus glycoprotein E2 products with different C termini. J Virol. 1994 Oct;68(10):6215–6222. doi: 10.1128/jvi.68.10.6215-6222.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Nilsson B., Anderson S. Proper and improper folding of proteins in the cellular environment. Annu Rev Microbiol. 1991;45:607–635. doi: 10.1146/annurev.mi.45.100191.003135. [DOI] [PubMed] [Google Scholar]
  25. Pettersson R. F. Protein localization and virus assembly at intracellular membranes. Curr Top Microbiol Immunol. 1991;170:67–106. doi: 10.1007/978-3-642-76389-2_3. [DOI] [PubMed] [Google Scholar]
  26. Pillez A., Slama A., Ciofi P., Tramu G., Epelbaum J., Beauvillain J. C. Immunocytochemical and in vitro autoradiographic evidence for a direct somatostatinergic modulation of the enkephalinergic hypothalamoseptal tract of the guinea-pig. Neuroscience. 1994 Jan;58(1):207–215. doi: 10.1016/0306-4522(94)90168-6. [DOI] [PubMed] [Google Scholar]
  27. Ralston R., Thudium K., Berger K., Kuo C., Gervase B., Hall J., Selby M., Kuo G., Houghton M., Choo Q. L. Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses. J Virol. 1993 Nov;67(11):6753–6761. doi: 10.1128/jvi.67.11.6753-6761.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Selby M. J., Glazer E., Masiarz F., Houghton M. Complex processing and protein:protein interactions in the E2:NS2 region of HCV. Virology. 1994 Oct;204(1):114–122. doi: 10.1006/viro.1994.1515. [DOI] [PubMed] [Google Scholar]
  29. Shimizu Y. K., Purcell R. H., Yoshikura H. Correlation between the infectivity of hepatitis C virus in vivo and its infectivity in vitro. Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6037–6041. doi: 10.1073/pnas.90.13.6037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Shindo M., Di Bisceglie A. M., Akatsuka T., Fong T. L., Scaglione L., Donets M., Hoofnagle J. H., Feinstone S. M. The physical state of the negative strand of hepatitis C virus RNA in serum of patients with chronic hepatitis C. Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8719–8723. doi: 10.1073/pnas.91.18.8719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Tanaka T., Kato N., Cho M. J., Sugiyama K., Shimotohno K. Structure of the 3' terminus of the hepatitis C virus genome. J Virol. 1996 May;70(5):3307–3312. doi: 10.1128/jvi.70.5.3307-3312.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Thomssen R., Bonk S., Propfe C., Heermann K. H., Köchel H. G., Uy A. Association of hepatitis C virus in human sera with beta-lipoprotein. Med Microbiol Immunol. 1992;181(5):293–300. doi: 10.1007/BF00198849. [DOI] [PubMed] [Google Scholar]
  33. Thomssen R., Bonk S., Thiele A. Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins. Med Microbiol Immunol. 1993 Dec;182(6):329–334. doi: 10.1007/BF00191948. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES